N-methyl-N-octadec-9-enyloctadec-9-en-1-amine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-methyl-N-octadec-9-enyloctadec-9-en-1-amine
• 化学式: C₃₇H₇₃N
• 分子量: 532.0
• InChiKey: KZWFMOHCIQNTCU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  16.1
• 重原子数：
  38
• 可旋转键数：
  32
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• LIPID NANO PARTICLES COMPRISING COMBINATION OF CATIONIC LIPID
  申请人：KYOWA HAKKO KIRIN CO., LTD.

  公开号：US20140045913A1

  公开（公告）日：2014-02-13

  The present invention provides a lipid nano-particles, which allow nucleic acids to be easily introduced into cells, comprising a cationic lipid represented by formula (I) (wherein: R 1 and R 2 are, the same or different, alkenyl, etc, and X 3 is absent or is alkyl, etc, X 1 and X 2 are hydrogen atoms, or are combined together to form a single bond or alkylene, and Y 1 is absent or anion, L 1 is a single bond, etc, R 3 is alkyl, etc), and a cationic lipid represented by formula (II) (wherein: R 4 and R 5 are, the same or different, alkenyl, etc, and X 4 and X 5 are hydrogen atoms, or are combined together to form a single bond or alkylene, and X 6 is absent or is alkyl, etc, Y 2 is absent or anion, a and b are, the same or different, 0 to 3, and L 4 is a single bond, etc, R 6 is alkyl, etc, L 2 and L 3 are —O—, —CO—O— or —O—CO—), and the like.

  本发明提供了一种脂质纳米粒子，可以使核酸轻松地进入细胞，包括由式(I)表示的阳离子脂质（其中：R1和R2是相同或不同的烯基等，X3不存在或是烷基等，X1和X2是氢原子，或结合在一起形成单键或亚烷基，Y1不存在或是阴离子，L1是单键等，R3是烷基等），以及由式(II)表示的阳离子脂质（其中：R4和R5是相同或不同的烯基等，X4和X5是氢原子，或结合在一起形成单键或亚烷基，X6不存在或是烷基等，Y2不存在或是阴离子，a和b是相同或不同的0到3，L4是单键等，R6是烷基等，L2和L3是—O—，—CO—O—或—O—CO—）等。
• LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：US20140039032A1

  公开（公告）日：2014-02-06

  The present invention provides a lipid nano-particles, which allow nucleic acids to be easily introduced into cells, comprising a cationic lipid represented by formula (I) (wherein: R 1 and R 2 are, the same or different, alkenyl, etc, and X 3 is absent or is alkyl, etc, X 1 and X 2 are hydrogen atoms, or are combined together to form a single bond or alkylene, and Y 1 is absent or anion, L 1 is a single bond, etc, R 3 is alkyl, etc), and the like.

  本发明提供了一种脂质纳米粒子，允许核酸轻松地被引入细胞中，包括由式(I)表示的阳离子脂质（其中：R1和R2是相同或不同的烯基等，X3不存在或是烷基等，X1和X2是氢原子，或结合在一起形成单键或亚烷基，Y1不存在或是阴离子，L1是单键等，R3是烷基等），等等。
• RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF KRAS GENE
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：US20140044755A1

  公开（公告）日：2014-02-13

  The present invention provides a composition for suppressing the expression of a KRAS gene, comprising a lipid particle containing, as a drug, a double-stranded nucleic acid having an antisense strand having a sequence of bases complementary to the sequence of at least 19 continuous bases of any one KRAS gene's mRNA of sequence Nos. 1 to 3; and a cationic lipid represented by the following formula (I): wherein R 1 and R 2 , which are the same or different, are each linear or branched alkyl, alkenyl or alkynyl having a carbon number of from 12 to 24; L 1 and L 2 , which are the same or different, are each —CO—O— or —O—CO—; a and b, which are the same or different, are each 1 to 3; and R 3 is a hydrogen atom, alkyl having a carbon number of from 1 to 6, or alkenyl having a carbon number of from 3 to 6, and the like.

  本发明提供了一种用于抑制KRAS基因表达的组合物，包括含有脂质颗粒的药物，该药物是具有与序列号为1至3的任一KRAS基因的mRNA的至少19个连续碱基序列互补的反义链的双链核酸；以及由以下式（I）表示的阳离子脂质： 其中 R1和R2，相同或不同，分别是线性或支链烷基，烯基或炔基，碳数为12至24； L1和L2，相同或不同，分别是—CO—O—或—O—CO—； a和b，相同或不同，分别为1至3； R3是氢原子，碳数为1至6的烷基，或碳数为3至6的烯基等。
• METHOD OF PRODUCING EPOXY COMPOUNDS
  申请人：Uchida Hiroshi

  公开号：US20110263882A1

  公开（公告）日：2011-10-27

  Provided is a method of efficiently producing an epoxy compound from an allyl ether having an aromatic ring under mild conditions by using hydrogen peroxide as an oxidizing agent without using an organic solvent. The method of producing an epoxy compound comprises reacting an allyl ether having an aromatic ring with hydrogen peroxide to epoxidize a carbon-carbon double bond of an allyl group to thereby produce a corresponding epoxy compound having an aromatic ring, wherein water only is used as a solvent without using an organic solvent, and a tungsten compound, and a tertiary amine and/or a quaternary ammonium salt, are used as a reaction catalyst.

  提供了一种在温和条件下使用过氧化氢作为氧化剂，而无需使用有机溶剂，从具有芳香环的烯丙基醚高效生产环氧化合物的方法。生产环氧化合物的方法包括将具有芳香环的烯丙基醚与过氧化氢反应，使烯丙基团的碳-碳双键环氧化，从而产生具有芳香环的相应环氧化合物，其中仅使用水作为溶剂，不使用有机溶剂，并且使用钨化合物、三级胺和/或季铵盐作为反应催化剂。
• Polyethylene composition and process for producing same
  申请人：TOSOH CORPORATION

  公开号：US20040214953A1

  公开（公告）日：2004-10-28

  A polyethylene composition prepared by polymerizing ethylene and an optional olefin with ≧3 carbon atoms in the presence of a macromonomer, is provided. The macromonomer is a vinyl-terminated ethylene polymer prepared by polymerizing ethylene and an optional olefin with ≧3 carbon atoms, and the macromonomer has (A) Mn≧5,000, and Mw/Mn=2-5. The polyethylene composition comprises (C) branched polyethylene prepared by copolymerizing ethylene, the macromonomer and an optional olefin with ≧3 carbon atoms, and the macromonomer. The polyethylene composition has (D) a density of 0.890-0.980 g/cm 3 , (E) Mw=30,000-10,000,000, (F) Mw/Mn=2-30, (G) a long chain branch frequency of 0.01-3 per 1,000 C atoms, and (H) a shrinking factor (g′ value) of 0.1-0.9 as measured by GPC/intrinsic-viscosity. The polyethylene composition can be finely divided particles having (P) a powder bulk density of 0.15-0.50 g/cm 3 .

  本发明提供了一种聚乙烯组合物，其是通过在存在大分子单体的情况下聚合乙烯和可选的具有≥3个碳原子的烯烃制备的。所述大分子单体是通过聚合乙烯和可选的具有≥3个碳原子的烯烃制备的，其具有(A) Mn≥5,000，且Mw/Mn=2-5的乙烯基端的聚合物。所述聚乙烯组合物包括(C)支化聚乙烯，其是通过共聚乙烯、大分子单体和可选的具有≥3个碳原子的烯烃制备的。所述聚乙烯组合物具有(D)密度为0.890-0.980 g/cm3，(E) Mw=30,000-10,000,000，(F) Mw/Mn=2-30，(G) 0.01-3个每1,000个C原子的长链支化频率，以及(H) 通过GPC/内禀粘度测量的收缩因子（g'值）为0.1-0.9。所述聚乙烯组合物可以是具有(P)粉末堆密度为0.15-0.50 g/cm3的细分散粒子。